RE: Director Buys16 Feb 2022 09:06
One problem here is the kind of news people would like, such as a big contract to bring in lots of quick revenue, isn't going to happen overnight. Taking licenced products through initial clinical stages takes time. Lots of time.
What's exciting for the scientists can be boring for investors. It's usually only headline grabbing positive results that can move the sp, in a meaningful way, as it can bring in lots of new investors.